Cancer Research UK Scotland Institute (formerly the CRUK Beatson Institute). Our Mission: Cancer discovery for patient benefit.
www.crukscotlandinstitute.ac.uk
Cancer Research UK Scotland Institute
⌛️There is still time to register for #BICC2026 "From Tumour Genesis to Metastasis: an immune perspective"
Don't miss out on the chance to hear from our fantastic speakers, including keynotes from Frances Balkwill, John Wherry and Karin de Visser!
www.beatsonconference.org/
MAPK-driven epithelial cell plasticity underlies colorectal cancer therapeutic resistance:
Members of our Cancer Cluster contributed to a recent paper that provides insight into resistance to therapy and suggests strategies that may improve therapeutic efficacy
nmgn.mrc.ukri.org/news/mapk-dr...
Our Best Models Working Group can offer advice on the use of a range of model systems.
The next in our series of #MeetTheExpert posts features Laura Greaves, whose group investigates the role of age-related mitochondrial DNA mutations in cancer biology
nmgn.mrc.ukri.org/working-grou...
Hooke Medal winner Stephen Tait @mitosrus.bsky.social @cruk-si.bsky.social is presented with his medal by BSCB president Laura Machesky before his fantastic medal talk on 'mitochondria, death and something in between' #DynamicCellVI
Cancer Research UK Scotland Institute
MRC National Mouse Genetics Network
MRC National Mouse Genetics Network
🚨Don't miss out! Early bird registration for #BICC2026 closes 1 April (10am BST)
Join global leaders in cancer immunology in Glasgow this June
📍 @cruk-si.bsky.social, Glasgow | 📅 22-25 June
#CancerResearch #Immunology
👇Register now👇
📣Register now for the Beatson International Cancer Conference 2026 ‘From Tumour Genesis to Metastasis: an immune perspective’
📅22-25 June 2026
📍CRUK Scotland Institute, Glasgow
🎟️Early Bird registration closes on 1 April
🔗 www.beatsonconference.org
#BICC2026 #CancerResearch #Immunology
🆕Paper from Naomi van den Berg (@naomiirisvdberg.bsky.social) in Cancer Cell proposes the "immunometabolic gatekeeping" framework to explain how tissue metabolism conditions tumour immunity
@crick.ac.uk @cruk-mi.bsky.social @uofgcancersciences.bsky.social
@cp-cancercell.bsky.social
We are delighted to announce that @mitosrus.bsky.social from @cruk-si.bsky.social @glasgow.ac.uk has been awarded the 2026 Hooke Medal
You can read about Stephen's work on mitochondria, cell death and cancer here:
bscb.org/hooke-medal-...
Cancer Research UK Scotland Institute
Cancer Research UK Scotland Institute
My first-author paper is out in @chemicalscience.rsc.org from my time in Professor Danny Huang’s laboratory @cruk-si.bsky.social. We showed that CBL can be used as a degrader E3 to target the “undruggable” eIF4E.
pubs.rsc.org/en/content/a...
British Society for Cell Biology
Cancer Research UK Scotland Institute
British Society for Cell Biology
Video
Alice Wicks
(White et al., Cancer Research UK Scotland Institute and collaborators across the MRC National Mouse Genetics Network – Cancer Cluster) Colorectal cancer (CRC) is a genetically complex disease, yet re...
📣Register now for the Beatson International Cancer Conference 2026 ‘From Tumour Genesis to Metastasis: an immune perspective’
📅22-25 June 2026
📍CRUK Scotland Institute, Glasgow
🎟️Early Bird registration closes on 1 April
🔗 www.beatsonconference.org
#BICC2026 #CancerResearch #Immunology
Why the link between immune infiltration and tumor control varies so strongly across
tissues remains unresolved. We propose the “immunometabolic gatekeeping” framework,
whereby tissue-intrinsic metabo...
Proteolysis Targeting Chimeras (PROTACs) are heterobifunctional molecules that recruit an ubiquitin ligase (E3) and a neo-substrate into a ternary complex, enabling selective protein degradation. Desp...
